Reassuring Data for Two High-Efficacy MS Meds in Pregnancy

Two longitudinal studies showed no adverse safety signals associated with prenatal exposure to two high-efficacy drugs for MS.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/reassuring-data-two-high-efficacy-ms-meds-pregnancy-2026a1000i10?src=rss

Author :

Publish date : 2026-05-29 17:27:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Reassuring Data for Two High-Efficacy MS Meds in Pregnancy

Chronic Spontaneous Urticaria Is More Than IgE: New Pathways Drive Targeted Care

Guselkumab Adds PsA Structural Damage Inhibition to Label

Related Posts

Abolishing patient watchdog leaves NHS ‘marking own homework’, councils warn

Targeted Lung Cancer Drug Aces Confirmatory Trial in Frontline Setting

Cardiac Amyloidosis Diagnosis Gets a More Extensive AI Model

Enhanced MRI Tops Ultrasound in Catching Early Liver Cancer

What Did FDA Vaccine Advisors Decide This Week?

No Difference in Complications for Chiari I Surgical Approaches in Kids, Study Shows

Abolishing patient watchdog leaves NHS ‘marking own homework’, councils warn

Targeted Lung Cancer Drug Aces Confirmatory Trial in Frontline Setting

Cardiac Amyloidosis Diagnosis Gets a More Extensive AI Model

Enhanced MRI Tops Ultrasound in Catching Early Liver Cancer

What Did FDA Vaccine Advisors Decide This Week?

No Difference in Complications for Chiari I Surgical Approaches in Kids, Study Shows

Bispecific Antibody Boosts Survival in Relapsed/Refractory Multiple Myeloma

PCSK9 Inhibitors Linked to Better Survival in Some Cancer Patients on Immunotherapy

Categories

Archives